|
WO2020260423A1
|
|
Freeze-dried composition for preparing calibrated gas-filled microvesicles
|
|
WO2020260420A1
|
|
Freeze-dried composition for preparing calibrated gas-filled microvesicles
|
|
US2020360289A1
|
|
Freeze-dried product and gas-filled microvesicles suspension
|
|
WO2020127816A1
|
|
Gas-filled microvesicles with ligand
|
|
WO2020127124A1
|
|
Optimized process for dimeric peptide-phospholipid conjugate
|
|
US2020360540A1
|
|
Freeze-dried product and gas-filled microvesicles suspension
|
|
CN112165959A
|
|
Lyophilized formulations for gas-filled microvesicles
|
|
CA3091952A1
|
|
Preparation of size-controlled microvesicles
|
|
US10335502B1
|
|
Freeze-dried formulation for gas-filled microvesicles
|
|
US2019053791A1
|
|
Initialization of fitting parameters for perfusion assessment based on bolus administration
|
|
US10232061B1
|
|
Freeze-dried formulation for gas-filled microvesicles
|
|
CN110536896A
|
|
The purification process of soluble PSGL-1 protein variant
|
|
EP3506882A1
|
|
Preparation of size-controlled microparticles
|
|
AU2017218024A1
|
|
A recombinant chimeric protein for selectins targeting
|
|
EP3414261A1
|
|
A recombinant chimeric protein for selectins targeting
|
|
EP3397308A1
|
|
Method and device of making a suspension of microparticles homogeneously distributed in an aqueous liquid carrier
|
|
KR20180099667A
|
|
Method and apparatus for making a suspension of microparticles homogeneously distributed in an aqueous liquid carrier
|
|
CN108289654A
|
|
Immobilization contrast agent is detected by dynamic threshold value
|
|
US2017348401A1
|
|
Gas-filled microvesicles for use as vaccine
|
|
EP3233136A1
|
|
Targeted gas-filled microvesicles formulation
|
